What Does EpiEndo Pharmaceuticals Do?

Total employees18
HeadquartersKópavogur
Founded2014

EpiEndo Pharma is a clinical-stage biopharmaceutical company with a unique therapeutic approach to chronic respiratory diseases like COPD and asthma. Their focus is on developing novel, orally available macrolide compounds that repair and enhance the integrity of the lung's epithelial barrier, rather than relying on traditional anti-inflammatory or bronchodilator mechanisms. Their lead candidate, EP395 (Barriolide™), aims to address the underlying epithelial dysfunction contributing to these conditions, potentially offering a first-in-class treatment. The company is advancing EP395 through clinical trials to establish its safety and efficacy in patients.

Where Is EpiEndo Pharmaceuticals's Headquarters?

HQ Function

The Icelandic headquarters serves as the central hub for EpiEndo Pharma's research and development activities, clinical trial management, strategic planning, and corporate administration.

Notable Features:

Likely housed within a modern science park or dedicated biotech facility offering advanced laboratory and office spaces, typical for innovative biopharmaceutical companies. Specific architectural details are not widely publicized.

Work Culture:

The work culture at EpiEndo Pharma is expected to be highly collaborative, science-driven, and mission-focused, characterized by a dynamic start-up/biotech environment. Employees are likely dedicated to advancing novel treatments for significant unmet medical needs in respiratory health.

HQ Significance:

The Icelandic location highlights the country's supportive ecosystem for R&D and innovation in the life sciences, providing access to skilled talent and research collaborations.

Values Reflected in HQ: The headquarters likely reflects EpiEndo's core values of innovation, scientific excellence, patient-centricity, and integrity in its pursuit of groundbreaking therapies.

Location:

While headquartered in Iceland, EpiEndo Pharma operates with a global perspective, particularly in its clinical development programs. They engage with clinical research organizations (CROs), trial sites, and regulatory authorities in multiple countries to advance their drug candidates. Their research collaborations and potential future commercialization efforts will also necessitate international engagement.

Street Address:

Kársnesbraut 94

City:

Kópavogur

State/Province:

Capital Region (Höfuðborgarsvæðið)

Country:

Iceland

Where Else Does EpiEndo Pharmaceuticals Operate Around the World?

No additional office locations available.

Buying Intent Signals for EpiEndo Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading EpiEndo Pharmaceuticals? Meet the Executive Team

As of April 2025, EpiEndo Pharmaceuticals' leadership includes:

Maria Bech - Chief Executive Officer (CEO)
Prof. Friðrik Rúnar Garðarsson - Chief Scientific Officer (CSO) & Founder
Dr. Ginny Norris - Chief Medical Officer (CMO)
Páll Ragnar Jóhannesson - Chief Financial Officer (CFO)
Dr. Ivar S. Olafsson - Board Member (Former CFO)
Dr. Clive Page - Chairman of the Board

Who's Investing in EpiEndo Pharmaceuticals?

EpiEndo Pharmaceuticals has been backed by several prominent investors over the years, including:

ABC Ventures
Flerie Invest
Eir Ventures
EIC Fund (European Innovation Council Fund)
Private Icelandic and International Investors

What Leadership Changes Has EpiEndo Pharmaceuticals Seen Recently?

Hire1
Exits0

EpiEndo Pharma announced a key CFO transition in early 2024, appointing Páll Ragnar Jóhannesson to the role.

New Appointments:

Páll Ragnar Jóhannesson, Páll Ragnar Jóhannesson was appointed as the new Chief Financial Officer.

What Technology (Tech Stack) Is Used byEpiEndo Pharmaceuticals?

Discover the tools EpiEndo Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

EpiEndo Pharmaceuticals Email Formats and Examples

While EpiEndo Pharma does not publicly disclose its exact email format, common patterns for companies of its size and industry include [first_initial][last]@domain.com or [first].[last]@domain.com. These are estimations.

[first_initial][last]@epiendopharma.com or [first].[last]@epiendopharma.com

Format

mbech@epiendopharma.com (example based on CEO's name and common format)

Example

70%

Success rate

What's the Latest News About EpiEndo Pharmaceuticals?

EpiEndo Pharma Press ReleaseFebruary 21, 2024

EpiEndo Pharma's EP395 (Barriolide™) Shows Promise in COPD: Phase 2a Clinical Trial Results to be Presented at AAAAI

EpiEndo Pharma announced positive topline results from its Phase 2a clinical trial of EP395 in COPD patients. The study met its primary endpoint of safety and tolerability and showed promising effects on biomarkers related to airway inflammation and epithelial integrity....more

EpiEndo Pharma Press ReleaseFebruary 7, 2024

EpiEndo Pharma Announces CFO Transition

EpiEndo Pharma announced the appointment of Páll Ragnar Jóhannesson as its new Chief Financial Officer, succeeding Dr. Ivar S. Olafsson, who will continue to serve on the Board of Directors....more

EpiEndo Pharma Press ReleaseNovember 15, 2023

EpiEndo's Principal Investigator Dr. Wisia Wedzicha to Present at the 11th Annual COPD Conference

EpiEndo Pharma announced that Professor Wisia Wedzicha, a Principal Investigator for EpiEndo’s Phase 2a clinical study (EPICC), would present on 'Preventing COPD Exacerbations, an Unmet Need' at the 11th Annual COPD Conference....more

EpiEndo Pharma Press ReleaseMay 23, 2023

EpiEndo's Phase 2a Study of EP395 in COPD Patients (EPICC™) – First Patient Dosed

EpiEndo Pharma announced the dosing of the first patient in its Phase 2a clinical study (EPICC™) evaluating EP395 in patients with Chronic Obstructive Pulmonary Disease (COPD)....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including EpiEndo Pharmaceuticals, are just a search away.